Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01109576 · ClinicalTrials.gov registry record · Early Phase 1
Workshops for Veterans With Vision and Hearing Loss
A Early Phase 1 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
NCT01109576: Completed Early Phase 1 study, sponsored by US Department of Veterans Affairs.
NCT01109576 is a Early Phase 1 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 13 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01109576, a Early Phase 1 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is a pilot study of workshops to help Veterans with both vision and hearing loss live a happier, fuller and less stressful life. The results will be used to guide the development of a large scale clinical trial.
Primary Outcome
The change in Profile of Mood States total score is defined as the 8 week follow-up total score minus the baseline POMS total score. The scale measures change in mood states before and after treatment. The change score can range from -232 to 232, with negative values indicating greater reduction in emotional distress.
Interventions
- BEHAVIORAL DSL Workshop
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-08 |
| Phase | Early Phase 1 |
What the finished NCT01109576 record still lists
NCT01109576 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which DSL Workshop is the first listed.
NCT01109576 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01109576 about?
NCT01109576 is a clinical study titled "Workshops for Veterans With Vision and Hearing Loss". This is a pilot study of workshops to help Veterans with both vision and hearing loss live a happier, fuller and less stressful life. The results will be used to guide the development of a large scale clinical trial.
What is the current status of trial NCT01109576?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2011-11. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01109576?
The interventions under investigation include: DSL Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT01109576?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01109576's enrollment target sits among peer trials
13 1504th of 2000 higher than 472 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia